NEUROFIBROMATOSIS
Clinical trials for NEUROFIBROMATOSIS explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer drug repurposed to shrink NF1 skin bumps in early trial
Disease control Recruiting nowThis early-stage study tests if a drug called IMLYGIC, already used for certain skin cancers, can safely treat painful or disfiguring skin bumps (cutaneous neurofibromas) in adults with NF1. Ten participants will receive up to 4 cycles of injections directly into their tumors. Th…
Matched conditions: NEUROFIBROMATOSIS
Phase: PHASE1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Russian study aims to map neurofibromatosis in adults
Knowledge-focused Recruiting nowThis study is gathering information about 200 adults in Russia who have neurofibromatosis type 1 (NF1) with plexiform neurofibromas. Researchers will collect data on patients' age, symptoms, medical history, and other health conditions. The goal is to better understand the diseas…
Matched conditions: NEUROFIBROMATOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 26, 2026 03:35 UTC
-
NF2 patients wanted for Decade-Long observation study
Knowledge-focused Recruiting nowThis study follows 269 people aged 8 to 75 with neurofibromatosis type 2 (NF2) for up to 10 years. Researchers will track tumor growth, hearing, speech, and other health changes using yearly scans and tests. The goal is to better understand how NF2 progresses, not to test a new t…
Matched conditions: NEUROFIBROMATOSIS
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated May 26, 2026 02:47 UTC